Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,400 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
The Journal of Infectious Diseases, 2024Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19
Strunz B., Maucourant C., Mehta A. et al.
Olink Explore 3072/384
Science Translational Medicine, 2024APOE from patient-derived astrocytic extracellular vesicles alleviates neuromyelitis optica spectrum disorder in a mouse model
Jiang, S., Li et al.
Olink Target 96 Mouse
Cell Genomics, 2024Genetic associations with ratios between protein levels detect new pQTLs and reveal protein-protein interactions
Suhre K.
ESC Heart Failure, 2024Histological assessment of cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement
Beuthner B., Elkenani M., Evert K. et al.
Olink Target 96
Translational Oncology, 2024CT-guided high dose rate brachytherapy can induce multiple systemic proteins of proliferation and angiogenesis predicting outcome in HCC
Salvermoser L., Goldberg S., Alunni-Fabbroni M. et al.
International Journal of Cancer, 2024Exploring causal correlations between circulating levels of cytokines and colorectal cancer risk: A Mendelian randomization analysis
Meng C., Sun L., Shi J. et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2024Differences in Cardiometabolic Proteins in Pregnancy Prioritize Relevant Targets of Preeclampsia
Lindley K., Perry A., Jacobs M. et al.
Frontiers in Immunology, 2024Vitreous Olink proteomics reveals inflammatory biomarkers for diagnosis and prognosis of traumatic proliferative vitreoretinopathy
Guo H., Wang T., Yu J. et al.
Frontiers in Immunology, 2024Evaluating the effects of circulating inflammatory proteins as drivers and therapeutic targets for severe COVID-19
Baranova A., Luo J., Fu L. et al.
Acta Biomaterialia, 2024Increased matrix stiffness enhances pro-tumorigenic traits in a physiologically relevant breast tissue- monocyte 3D model
Abrahamsson A., Boroojeni F., Naeimipour S. et al.
Annals of the Rheumatic Diseases, 2024Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker
Ea H., Kischkel B., Chirayath T. et al.
Advances in Rheumatology, 2024Inflammatory cytokines and their potential role in Sjogren’s syndrome risk: insights from a mendelian randomization study
Shi W., Xu Y., Zhang A. et al.
Cardiovascular Diabetology, 2024Association of plasma angiogenin with risk of major cardiovascular events in type 2 diabetes
Gurung R., Liu S., Liu J. et al.
Frontiers in Immunology, 2024Exploring candidate biomarkers for rheumatoid arthritis through cardiovascular and cardiometabolic serum proteome profiling
Cuesta-López L., Escudero-Contreras A., Hanaee Y. et al.
Mechanisms of Ageing and Development, 2024Common and distinct metabolomic markers related to immune aging in Western European and East African populations
Bulut O., Temba G., Koeken V. et al.
Molecular Metabolism, 2024Intermittent rapamycin feeding recapitulates some effects of continuous treatment while maintaining lifespan extension
Baghdadi M., Nespital T., Monzó C. et al.
BMC Cardiovascular Disorders, 2024Association between C10X polymorphism in the CARD8 gene and inflammatory markers in young healthy individuals in the LBA study
Fransén K., Hiyoshi A., Paramel G. et al.
Nature Cardiovascular Research, 2024Markers of imminent myocardial infarction
Gustafsson S., Lampa E., Jensevik Eriksson K. et al.
Acta Haematologica, 2024Multiplex Proteomics in the Identification of Potential Biomarkers of Very Severe Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Hematopoietic Cell Transplant Patients Treated with Defibrotide
Vasudevan Nampoothiri R., Avery L., Pasic I. et al.
Redox Biology, 2024Vascular dysfunction and arterial hypertension in experimental celiac disease are mediated by gut-derived inflammation and oxidative stress
Keppeler K., Pesi A., Lange S. et al.
3556 publications
Items per page
2461-2480 of 3556 publications